Scinai Immunotherapeutics Ltd. Share Price
Stocks
SCNI
US09073Q4029
Biotechnology & Medical Research
|
Market Closed -
Nasdaq
20:00:00 30/10/2026 GMT
|
5-day change | 1st Jan Change | ||
| 0.4716 USD | -9.05% |
|
-16.46% | -93.38% |
| 10-15 | Scinai Immunotherapeutics Ltd. announced that it has received $2.95 million in funding | CI |
| 10-14 | Scinai Immunotherapeutics Ltd. announced that it expects to receive $2.95 million in funding | CI |
| Market Cap | 269K 241K 221K 201K 375K 25.52M 382K 2.64M 1.06M 13.43M 1.01M 987K 42.34M | P/E 2024 * |
-
| P/E 2025 | -0.2x |
|---|---|---|---|---|---|
| Enterprise Value | 875K 783K 721K 653K 1.22M 83.06M 1.24M 8.59M 3.45M 43.69M 3.28M 3.21M 138M | EV / Sales 2024 |
4,521,658x | EV / Sales 2025 | 2,346,086x |
| Free-Float |
0.36% | Yield 2024 * |
-
| Yield 2025 | - |
NasdaqUSD
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| SCNI | Delayed | |
CBOE
| SCNI | Real-time | |
|
Deutsche Boerse AG
| 2F50 | Delayed |
Last Transcript: Scinai Immunotherapeutics Ltd.
| 1 day | -9.05% | ||
| 1 week | -16.46% | ||
| 1 month | -66.79% | ||
| 3 months | -82.73% | ||
| 6 months | -93.63% | ||
| Current year | -93.38% |
| 1 week | 0.47 |  | 0.57 |
| 1 month | 0.47 | | 1.76 |
| Current year | 0.47 | | 11.2 |
| 1 year | 0.47 | | 15.5 |
| 3 years | 0.47 | | 89.2 |
| 5 years | 0.47 | | 3,490 |
| 10 years | 0.47 | | 61,999.9 |
| Manager | Title | Age | Since |
|---|---|---|---|
Amir Reichman
CEO | Chief Executive Officer | 51 | 01/03/2021 |
Uri Ben-Or
DFI | Director of Finance/CFO | 55 | 31/12/2006 |
Dalit Fischer
CTO | Chief Tech/Sci/R&D Officer | - | 31/12/2021 |
| Director | Title | Age | Since |
|---|---|---|---|
Mark Germain
CHM | Chairman | 77 | 29/09/2019 |
Samuel Moed
BRD | Director/Board Member | 64 | 23/03/2020 |
Adi Raviv
BRD | Director/Board Member | 71 | 23/03/2020 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 18/03/26 | Other | Chief Financial Officer | 35,848,348 | 1.0507% | ||
| 18/03/26 | Other | Director | 57,400,000 | 1.6823% | ||
| 18/03/26 | Other | Director | 60,400,000 | 1.7702% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -9.05% | -16.46% | -96.63% | -99.29% | 269K | |
| -0.62% | -1.87% | +42.87% | +64.15% | 63.77B | |
| +0.35% | +3.20% | +14.40% | +81.76% | 56.37B | |
| +0.53% | +1.96% | +16.24% | +103.35% | 54.62B | |
| -2.81% | -4.31% | +23.50% | +47.83% | 44.06B | |
| -0.33% | -1.93% | +19.28% | +98.80% | 42.11B | |
| +0.55% | +2.31% | +225.14% | +866.21% | 41B | |
| +3.27% | +47.96% | +112.84% | +96.58% | 34.92B | |
| +1.22% | -1.44% | +14.57% | +46.95% | 32.82B | |
| +0.89% | +20.55% | -40.62% | +349.24% | 24.7B | |
| Average | -0.60% | +5.14% | +33.16% | +165.56% | 39.43B | |
| Weighted average by Cap. | +0.18% | +5.44% | +47.99% | +176.67% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 0.66 0.59 0.54 0.49 0.92 62.48 0.94 6.46 2.59 32.86 2.47 2.42 103.64 | 1.31 1.17 1.08 0.98 1.83 124.48 1.86 12.88 5.17 65.48 4.92 4.82 206.5 |
| Net income | 4.8M 4.3M 3.95M 3.58M 6.69M 455M 6.82M 47.12M 18.91M 240M 18M 17.62M 755M | -8.31M -7.44M -6.84M -6.2M -11.59M -789M -11.81M -81.61M -32.76M -415M -31.18M -30.51M -1.31B |
| Net Debt | 122K 109K 101K 91.07K 170K 11.58M 173K 1.2M 481K 6.09M 458K 448K 19.22M | 606K 543K 499K 452K 846K 57.54M 861K 5.95M 2.39M 30.27M 2.27M 2.23M 95.45M |
Employees
45
| Date | Price | Change | Volume |
|---|---|---|---|
| 30/10/26 | US$0.4716 | -9.05% | 52,954 |
| 29/10/26 | US$0.5185 | -2.92% | 46,011 |
| 28/10/26 | US$0.5341 | +0.58% | 39,406 |
| 27/10/26 | US$0.5310 | -1.94% | 50,187 |
| 26/10/26 | US$0.5415 | -4.07% | 122,313 |
Annual profits - Rate of surprise
- Stock Market
- Stocks
- SCNI Stock
Select your edition
All financial news and data tailored to specific country editions
